With the addition of two new directors, Angeion Corp. (NSDQ:ANGN) neared the completion of a board restructuring stipulated by an agreement with major shareholder BlueLine Partners LLC.

The St. Paul, Minn.-based cardiorespiratory diagnostic equipment maker appointed Mark Sheffert, who was subsequently elected chairman, and Robert Munzenrider was elected as a sixth director and will serve as chair of the board’s audit committee.